Beranda › Degenerasi Makula › Tennessee
Uji klinis Degenerasi Makula di Tennessee
7 studi untuk Degenerasi Makula mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Charles Retina Institute, Germantown
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07440225A Study in Adults With Geographic Atrophy
- Tennessee Retina, PC, Nashville
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Tennessee Retina, PC, Nashville
- Vanderbilt Eye Institute, Nashville
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Vanderbilt Eye Institute, Nashville
Menerima pesertaFase 2
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Tennessee Retina, Nashville
Menerima pesertaFase 1/2
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Southeastern Retina Associates, Hixson
- Southeastern Retina Associates (Site 095), Johnson City
- Southeastern Retina Associates, P.C., Knoxville
- dan 1 lainnya
Menerima pesertaFase 2/3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07496567Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Tennessee Retina, PC, Nashville
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07064759Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.